vs

Side-by-side financial comparison of CITIUS ONCOLOGY, INC. (CTOR) and Robin Energy Ltd. (RBNE). Click either name above to swap in a different company.

CITIUS ONCOLOGY, INC. is the larger business by last-quarter revenue ($3.9M vs $3.6M, roughly 1.1× Robin Energy Ltd.).

Citius Oncology, Inc. is a late-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer patients. Its core pipeline covers treatments addressing unmet medical needs in hematologic malignancies and solid tumors, primarily serving North American and global oncology care markets.

NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.

CTOR vs RBNE — Head-to-Head

Bigger by revenue
CTOR
CTOR
1.1× larger
CTOR
$3.9M
$3.6M
RBNE

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
CTOR
CTOR
RBNE
RBNE
Revenue
$3.9M
$3.6M
Net Profit
$-5.5M
Gross Margin
80.0%
Operating Margin
-133.2%
12.1%
Net Margin
-140.3%
Revenue YoY
Net Profit YoY
16.9%
EPS (diluted)
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTOR
CTOR
RBNE
RBNE
Cash + ST InvestmentsLiquidity on hand
$7.3M
$39.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$58.4M
$20.5M
Total Assets
$110.0M
$48.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTOR
CTOR
RBNE
RBNE
Q4 25
$7.3M
Q2 25
$39.4M
Stockholders' Equity
CTOR
CTOR
RBNE
RBNE
Q4 25
$58.4M
Q2 25
$20.5M
Total Assets
CTOR
CTOR
RBNE
RBNE
Q4 25
$110.0M
Q2 25
$48.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTOR
CTOR
RBNE
RBNE
Operating Cash FlowLast quarter
$-7.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTOR
CTOR
RBNE
RBNE
Q4 25
$-7.4M
Q2 25
Capex Intensity
CTOR
CTOR
RBNE
RBNE
Q4 25
Q2 25
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons